Quince Therapeutics Acquires Orphai and Secures $187M Financing to Advance Pulmonary Rapamycin Pipeline
Quince Therapeutics Announces Acquisition of Orphai and Up t...
Sign in to continue:
Quince Therapeutics Announces Acquisition of Orphai and Up t...
FoundPac Group Berhad Q3 2026 Financial Results Analysis F...
Pos Malaysia Berhad Releases Q1 2026 Interim Financial Resul...
Choo Bee Metal Industries Berhad Q1 2026 Financial Results: ...
Kuala Lumpur Kepong Berhad Q2 2026 Results: Strong Profit Gr...
TSA Group Berhad Q1 2026 Financial Results and Key Investor ...
Sunway Construction Group Berhad Q1 2026 Results: Profit Sur...
M & A Equity Holdings Berhad Posts Higher Net Profit Despite...
SIN-KUNG LOGISTICS BERHAD: Q1 2026 Interim Financial Report ...
Keppel’s Response to IMDA’s Suspension of M1-SIMBA Deal: Key...